Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
64.35
-0.41 (-0.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
(VKTX) - Analyzing Viking Therapeutics's Short Interest
August 21, 2024
Via
Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Via
Talk Markets
Unpacking the Latest Options Trading Trends in Viking Therapeutics
August 20, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today
August 19, 2024
Via
Benzinga
Could Viking Therapeutics Become the Next Novo Nordisk?
August 17, 2024
Given this biotech's ascent, its odds of becoming a giant are better than most.
Via
The Motley Fool
3 Promising Biotech Stocks for the Long-Term: August 2024
August 13, 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
August 05, 2024
Via
Benzinga
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
July 26, 2024
Via
Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
August 12, 2024
There isn't much to suggest these businesses are actually vulnerable.
Via
The Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
News from a competitor gave investors an unwelcome dose of reality.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.
Via
The Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
August 01, 2024
Anti-obesity therapeutics are all the rage and for good reason. Investors seeking to profit should consider these weight loss stocks.
Via
InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
Via
Benzinga
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
August 01, 2024
Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
July 30, 2024
Via
Benzinga
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
July 30, 2024
Both companies have a clear path to competing successfully in the market.
Via
The Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
July 29, 2024
Discover three overlooked breakout stocks with solid growth prospects, perfect for enhancing your investment portfolio.
Via
InvestorPlace
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
July 29, 2024
The Federal Reserve's fight against inflation may soon yield financial benefits.
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
July 29, 2024
One preliminary piece of evidence is sending its shares higher.
Via
The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
July 29, 2024
Should you get in on this stock now?
Via
The Motley Fool
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
July 28, 2024
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%
Via
Benzinga
Is Viking Therapeutics a Millionaire-Maker Stock?
July 27, 2024
The stock rose 120% in one trading session earlier this year on positive clinical trial news.
Via
The Motley Fool
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
July 26, 2024
Small caps continued to lead, while the Nasdaq broke below key levels.
Via
Investor's Business Daily
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
July 25, 2024
Companies like Novo Nordisk and Eli Lilly might soon have a determined competitor in their hottest product category.
Via
The Motley Fool
Novo Nordisk Shares Decline Amid Competitive Pressure
July 25, 2024
Novo Nordisk A/S Common Stock (NYSE: NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).
Via
Benzinga
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
July 25, 2024
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 25, 2024
Via
Benzinga
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
July 25, 2024
Viking Therapeutics Inc (NASDAQ:VKTX) shares are rising Thursday after the biotech company announced plans to advance its experimental weight loss drug to late-stage trials.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.